Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer

Oncogene

Volumn 32, Issue 27, 2013, Pages 3274-3285

  Razandi, M ^a,b   Pedram, A ^a,b   Jordan, V C ^c   Fuqua, S ^d   Levin, E R ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Estrogen receptor; Mitochondria; Tamoxifen resistance

Indexed keywords

CASPASE 7; CYTOCHROME C; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LIPOCORTIN 5; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN KINASE C DELTA; REACTIVE OXYGEN METABOLITE; ROTENONE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TAMOXIFEN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER RESISTANCE; CELL DEATH; CELL FATE; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; MITOCHONDRION; MOUSE; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; MICE; MICE, NUDE; MITOCHONDRIA; REACTIVE OXYGEN SPECIES; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SUPEROXIDE DISMUTASE; TAMOXIFEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84880311908     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.335     Document Type: Article

References (54)

1. Han P, Kang JH, Li HL, Hu SX, Lian HH, Qiu PP et al. Antiproliferation and apoptosis induced by tamoxifen in human bile duct carcinoma QBC939 cells via upregulated p53 expression. Biochem Biophys Res Commun 2009; 385: 251-256.
2. Huang CC, Cheng HH, Lin KL, Cheng JS, Tsai JY, Liao WC et al. Tamoxifen-induced [Ca2+]I rise and apoptosis in corneal epithelial cells. Toxicology 2009; 255: 58-64.
3. Moriai R, Tsuji N, Moriai M, Kobayashi D, Watanabe N. Survivin plays as a resistant factor against taxoxifen-induced apoptosis in human breast cancer cells. Breast Cancer Res Treat 2009; 117: 261-271.
4. Luce A, Courtin A, Levalois C, Altmeyer-Morel S, Romeo PH, Chevillard S et al. Death receptor pathways mediate targeted and non-targeted effects of ionizing radiations in breast cancer cells. Carcinogenesis 2009; 30: 432-439.
5. Chalut KJ, Ostrander JH, Giacomelli MG, Wax A. Light scattering measurements of subcellular structure provide noninvasive early detection of chemotherapyinduced apoptosis. Cancer Res 2009; 69: 1199-1204.
6. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 1998; 351: 1451-1467.
7. Arpino G, Weichmann L, Osborne CK, Schiff R. Cross talk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance. Endo Rev 2008; 29: 217-233.
8. Osborne CK, Bardou V, Hopp TA, Chamnes GC, Hilsenbeck SG, Fuqua SA et al. Role of the estrogen receptor co activator AIB1 (SRC-3) and Her2/neu in tamoxifen resistance in breast cancer. J Natl Canc Inst 2003; 95: 353-361.
9. Hurtado A, Holmes KA, Geistlinger TR, Hutcheson IR, Nicholson RI, Brown M et al. Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to 22 Mitochondrial ER and tamoxifentamoxifen. Nature 2008; 456: 663-666.
10. Pedram A, Razandi M, Wallace DC, Levin ER. Functional estrogen receptors in the mitochondria of breast cancer cells. Mol Biol Cell 2006; 17: 2125-2137.
11. Pedram A, Razandi M, O'Mahony F, Lubahn D, Levin ER. Estrogen receptor beta inhibits cardiac fibrosis. Mol Endocrinol 2010; 24: 2152-2165.
12. Xiao D, Powolny AA, Singh SV. Benzyl isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species dependent apoptosis in human breast cancer cells. J Biol Chem 2008; 283: 30151-30163.
13. Di X, Shiu RP, Newsham IF, Gewirtz DA. Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to adriamycin. Biochem Pharmacol 2009; 77: 1139-1150.
14. Chua PJ, Yip GW, Bay BH. Cell cycle arrest induced by hydrogen peroxide is associated with modulation of oxidative stress related genes in breast cancer cells. Exp Biol Med 2009; 234: 1086-1094.
15. Poyton RO, Ball KA, Castello PR. Mitochondrial generation of free radicals and hypoxic signaling. Trends Endocrinol Metab 2009; 20: 332-340.
16. Chapman KE, Sinclair SE, Zhuang D, Hassid A, Desai L, Waters CM. Cyclic mechanical strain increases reactive oxygen species production in pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 2005; 289: L834-L841.
17. James AM, Cocheme HM, Smith RA, Murphy MP. Interactions of mitochondriatargeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. J Biol Chem 2005; 280: 21295-21312.
18. Pedram A, Razandi M, Levin ER. Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol 2006; 20: 1996-2009.
19. Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, Katzenellenbogen BS. Activities of estrogen receptor alpha- and beta selective ligands at diverse estrogen responsive gene sites mediating transactivation or trans-repression. Mol Cell Endocrinol 2003; 206: 13-22.
20. Park WC, Liu H, Macgregor-Schafer J, Jordan VC. Deregulation of estrogen induced telomerase activity in tamoxifen-resistant breast cancer cells. Int J Oncol 2005; 27: 1459-1466.
21. Halliwell B. Antioxidant defense mechanisms: from the beginning to the end (of the beginning). Free Radic Res 1999; 31: 261-272.
22. Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000; 407: 390-395.
23. Lebovitz RM, Zhang H, Vogel H, Cartwright Jr J, Dionne L, Lu N et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci USA 1996; 93: 9782-9787.
24. MacMillan-Crow LA, Crow JP, Thompson JA. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry 1998; 37: 1613-1622.
25. Yamakura F, Taka H, Fujimura T, Murayama K. Inactivation of human manganesesuperoxide dismutase by peroxynitrite is caused by exclusivenitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem 1998; 273: 14085-14089.
26. Majumder PK, Mishra NC, Sun X, Bharti A, Kharbanda S, Saxena S et al. Targeting of protein kinase C delta to mitochondria in the oxidative stress response. Cell Growth Differ 2001; 12: 465-470.
27. Brodie C, Blumberg PM. Regulation of cell apoptosis by protein kinase C delta. Apoptosis 2003; 8: 19-27.
28. Mingo-Sion AM, Marietta PM, Koller E, Wolf DM, Van Den Berg CL. Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells. Oncogene 2004; 23: 596-604.
29. Mandlekar S, Kong AN. Mechanisms of tamoxifen-induced apoptosis. Apoptosis 2001; 6: 469-477.
30. Gross A, Jockel J, Wei MC, Korsmeyer SJ. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 1998; 17: 3878-3885.
31. Dejean LM, Martinez-Caballero S, Guo L, Hughes C, Teijido O, Ducret T et al. Oligomeric Bax is a component of the putative cytochrome c release channel MAC, mitochondrial apoptosis-induced channel. Mol Biol Cell 2005; 16: 2424-2432.
32. Jurgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 1998; 95: 4997-5002.
33. Benhar M, Engelberg D, Levitzki A. ROSstress-activated kinases and stress signaling in cancer. EMBO Rep 2002; 3: 420-425.
34. Aslan M, Ozben T. Oxidants in receptor tyrosine kinase signal transduction pathways. Antioxid Redox Signal 2003; 5: 781-788.
35. Felty Q, Singh KP, Roy D. Estrogen-induced G(1)/S transition of G(0)-arrested estrogen-dependent breast cancer cells is regulated by mitochondrial oxidant signaling. Oncogene 2005; 24: 4883-4893.
36. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 2005; 102: 719-724.
37. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanisahi H et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 2008; 320: 661-664.
38. Fan P, Wang J, Santen RJ, Yue W. Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MVF-7 breast cancer cells. Can Res 2007; 67: 1352-1360.
39. Van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW et al. A geneexpression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: 1999-2009.
40. Milanesi L, Vasconsuelo A, de Boland AR, Bland R. Expression and subcellular distribution of native estrogen receptor beta in murine C2C12 cells and skeletal muscle tissue. Steroids 2009; 74: 489-497.
41. Chen JQ, Delannoy M, Cooke C, Yager JD. Mitochondrial localization of ERalpha and ERbeta in human MCF7 cells. Am J Physiol Endocrinol Metab 2004; 286: E1011-E1022.
42. Yang SH, Liu R, Perez EJ, Wen Y, Stevens Jr SM, Valencia T et al. Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci USA 2004; 101: 4130-4135.
43. Flynn JM, Dimitrijevich SD, Younes M, Skliris G, Murphy LC, Cammarata PR. Role of wild-type estrogen receptor-beta in mitochondrial cytoprotection of cultured normal male and female human lens epithelial cells. Am J Physiol Endocrinol Metab 2008; 295: E637-E647.
44. Hsieh YC, Yu HP, Suzuki T, Choudhry MA, Schwacha MG, Bland KI et al. Upregulation of mitochondrial respiratory complex IV by estrogen receptor beta is critical for inhibiting mitochondrial apoptotic signaling and restoring cardiac functions following trauma-hemorrhage. J Mol Cell Cardiol 2006; 41: 511-521.
45. Fuqua SA, Cui Y. Estrogen and progesterone receptor isoforms: clinical significance in breast cancer. Breast Cancer Res Treat 2004; 87: S3-10.
46. Speirs V. The evolving role of oestrogen receptor beta in clinical breast cancer. Breast Cancer Res 2008; 10: 111.
47. Yamakura F, Taka H, Fujimura T, Murayama K. Inactivation of human manganesesuperoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem 1998; 273: 14085-14089.
48. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 1995; 11: 376-381.
49. Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD et al. SIRT3 is a mitochondria-localized tumor suppressorrequired for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 2010; 17: 41-51.
50. Tao R, Coleman MC, Pennington JD, Ozden O, Park SH, Jiang H et al. Sirt3- mediated deacetylation of evolutionarily conserved lysine 122regulates MnSOD activity in response to stress. Mol Cell 2010; 40: 893-903.
51. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009; 458: 780-783.
52. Barone I, Brusco L, Gu G, Selever J, Beyer A, Covington KR et al. Loss of Rho GDIa and resistance to tamoxifen via effects on estrogen receptor a. J Natl Cancer Inst 2011; 103: 538-552.
53. Trounce I, Kim YL, Jun AS, Wallace DC. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 1996; 264: 484-509.
54. Razandi M, Pedram A, Levin ER. Plasma membrane estrogen receptors signal to anti-apoptosis in breast cancer. Mol Endocrinol 2000; 14: 1434-1447.